Automated Nucleic Acid Purification Systems Market Size in 2022, Increasing demand, Growth strategies, Forecast to 2028

Automated Nucleic Acid Purification Systems are used to extract nucleic acid in front of molecular infectious disease assays, molecular oncology assays, molecular genetics assaysReport OverviewDue to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at USD million in the year 2022, is projected to reach a revised size of USD million by 2028, growing at a CAGR of percent during the forecast period 2022-2028.The USA market for Automated Nucleic Acid Purification Systems is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The China market for Automated Nucleic Acid Purification Systems is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The Europe market for Automated Nucleic Acid Purification Systems is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The global key manufacturers of Automated Nucleic Acid Purification Systems include MP Biomedicals, Thermo Fisher, Gilson, PerkinElmer, BioChain, Promega and Analytik Jena, etc. In 2021, the global top five players had a share approximately percent in terms of revenue.